(RTTNews) - CareDx (CDNA) said it expects third quarter revenue to be in the range of $82 million to $83 million, an increase of approximately 23% year-over-year. Testing services revenue is expected to be in the range of $60 million to $61 million, an increase of approximately 26% year-over-year. The company ended the quarter with cash, cash equivalents, and marketable securities of approximately $240 million with no debt.
"Our performance continues to be strong as we head into the fourth quarter," said John Hanna, CareDx President and CEO.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
